Novo partners with Hims & Hers again, ending GLP-1 spat Months of legal wrangling between Novo Nordisk and telehealth company Hims & Hers has been set aside, as the two companies agree to work together once again on the sale of GLP-1 agonists for weight loss
Should Phase 3 data prove favourable, a regulatory submission could follow, though the timing remains uncertain and no predictions should be drawn from the approval timelines of other medicine classes
More importantly, the decision reflects something bigger than a single drug
Exenatide can make it harder for your body to absorb other medicines you take by mouth
Besides countering oxidation, Glutathione also helps build tissues, facilitates their repair, aids in the production of specific proteins and chemicals essential to the body, and plays a crucial role in the immune system